CT
CELG

Clearstead Trust’s Celgene Corp CELG Stock Holding History

Clearstead Trust’s Portfolio CELG Stock Details CELG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-14
Closed -$1K – 237
2018
Q4 		$1K Sell
14
-1,264
-99% -$93.3K ﹤0.01% 221
2018
Q3 		$114K Buy
1,278
+2
+0.2% +$177 0.09% 107
2018
Q2 		$101K Buy
+1,276
New +$106K 0.09% 114
2018
Q1 		– Sell
-2,618
Closed -$273K – 213
2017
Q4 		$273K Sell
2,618
-449
-15% -$50.7K 0.19% 93
2017
Q3 		$447K Sell
3,067
-550
-15% -$74.9K 0.33% 76
2017
Q2 		$470K Buy
3,617
+1,617
+81% +$198K 0.37% 63
2017
Q1 		$249K Hold
2,000
– – 0.21% 86
2016
Q4 		$232K Buy
+2,000
New +$223K 0.21% 88

Other funds holding CELG

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
OAG
Orbis Allan Gray Hamilton, Bermuda $23.7B AUM 65.43% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Clearstead Trust's CELG Position: Q1 2019 in Review

Clearstead Trust sold out of Celgene Corp (CELG) in Q1 2019, closing a stake of 14 shares — an estimated $1K sold.

Clearstead Trust first reported a position in CELG in Q4 2016 and held it in 8 quarters. The position peaked at $470K in Q2 2017. 1,389 funds tracked by Wall St. Rank hold CELG as of Q1 2019.

  • Clearstead Trust reported no remaining Celgene Corp position as of Q1 2019 after selling out during the quarter.
  • Clearstead Trust sold 14 Celgene Corp shares in Q1 2019, an estimated $1K.
  • Clearstead Trust first reported a position in Celgene Corp in Q4 2016 and held it in 8 quarters.
  • Clearstead Trust's Celgene Corp position peaked at $470K in Q2 2017.
  • 1,389 funds tracked by Wall St. Rank held Celgene Corp as of Q1 2019.

Based on Clearstead Trust's 13F filing for Q1 2019, filed 13 May 2019.